Shengtai Pharmaceutical Stock Forecast, Price & News

0.00 (0.00 %)
(As of 05/7/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume8,568 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SGTI News and Ratings via Email

Sign-up to receive the latest news and ratings for Shengtai Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:SGTI
Phone86 53 6218 8831
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Next Earnings DateN/A
OptionableNot Optionable


No headlines for this company have been tracked by MarketBeat.com

About Shengtai Pharmaceutical

Shengtai Pharmaceutical, Inc., through its subsidiaries, engages in the manufacture and distribution of glucose and starch products in the People's Republic of China and internationally. The company provides pharmaceutical and medical grade products, including dextrose monohydrate, dextrose anhydrous, dextrin, and pharmaceutical grade cornstarch; and rough glucose, dextrose monohydrate oral, and food and beverage grade cornstarch for the food and beverage, and processing industries. It also offers other products comprising fibers, corn embryo, protein powder, mother liquid, and abamectin ointment. The company markets its products directly to healthcare institutions, medical supply companies, pharmaceutical companies, medical supply exporters, and food and beverage companies. Shengtai Pharmaceutical, Inc. was incorporated in 2004 and is based in Weifang, China.


Overall MarketRank

0.17 out of 5 stars

Medical Sector

1842nd out of 2,043 stocks

Pharmaceutical Preparations Industry

728th out of 770 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Shengtai Pharmaceutical (OTCMKTS:SGTI) Frequently Asked Questions

What stocks does MarketBeat like better than Shengtai Pharmaceutical?

Wall Street analysts have given Shengtai Pharmaceutical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Shengtai Pharmaceutical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Shengtai Pharmaceutical's key executives?

Shengtai Pharmaceutical's management team includes the following people:
  • Mr. Qingtai Liu, Chairman, CEO & Pres (Age 64)
  • Mr. Yongqiang Wang, CFO, Principal Accounting Officer, Financial Controller & Director (Age 52)

Who are some of Shengtai Pharmaceutical's key competitors?

What is Shengtai Pharmaceutical's stock symbol?

Shengtai Pharmaceutical trades on the OTCMKTS under the ticker symbol "SGTI."

How do I buy shares of Shengtai Pharmaceutical?

Shares of SGTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Shengtai Pharmaceutical's stock price today?

One share of SGTI stock can currently be purchased for approximately $0.02.

What is Shengtai Pharmaceutical's official website?

The official website for Shengtai Pharmaceutical is www.shengtaipharmaceutical.com.

Where are Shengtai Pharmaceutical's headquarters?

Shengtai Pharmaceutical is headquartered at CHANGDA ROAD EAST DEVELOPMENT DISTRICT CHANGLE COUNTY, SHANDONG F4, 262400.

How can I contact Shengtai Pharmaceutical?

Shengtai Pharmaceutical's mailing address is CHANGDA ROAD EAST DEVELOPMENT DISTRICT CHANGLE COUNTY, SHANDONG F4, 262400. The company can be reached via phone at 86 53 6218 8831 or via email at [email protected]

This page was last updated on 5/8/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.